Upgrade to SI Premium - Free Trial

Morgan Stanley Downgrades Merck (MRK) to Underweight

February 4, 2013 7:47 AM
Morgan Stanley downgraded Merck (NYSE: MRK) from Equalweight to Underweight.

NOTE: Second downgrade today.

For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.

Shares of Merck closed at $41.83 yesterday, with a 52 week range of $36.91-$48.00.

Categories

Downgrades

Next Articles